Case in point: Intermountain Healthcare recently announced it would conduct genomic testing on all newly diagnosed cancer patients – joining other industry-leading systems (Memorial Sloan Kettering and Geisinger, to name a few) with similar policies.
But a significant gap remains: While countless organizations are now ordering genomic tests, they lack the data management and point-of-care access to derive real value from these insights.
That’s where 2bPrecise comes in. We’re working with a wide variety of clients, helping them build an informatics strategy, whether their priority is pharmacogenomics, precision oncology or another clinical area – or an enterprise-wide initiative.
We enable healthcare organizations to get started with precision medicine anywhere they want – oncology? pediatrics? cardiology? pharmacogenomics?